Nebulizer Market is estimated to be US$ 2.29 billion by 2030 with a CAGR of 6.8% during the forecast period

Published Date: April 2024

Nebulizer is small machine that turns liquid medicine into a mist. It is a type of breathing machine that lets you inhale medicated vapors. While not always prescribed for a cough, nebulizers may used to relieve coughs and other symptoms caused by respiratory illnesses. They’re especially helpful for younger age groups who may have difficulty using handheld inhalers. Nebulizers are commonly used by the patients suffering from asthma, chronic obstructive pulmonary disease (COPD), cystic fibrosis, and other respiratory diseases or disorders. Nebulizers directly targets the respiratory area decreasing side effects and harm to other body organs and cells. Thus, it is much comfortable to use than other forms of ingested medicines. Growing incidence rate of chronic respiratory diseases, increasing demand for home healthcare devices, and rising geriatric population is leading to boost growth of the target market globally. Nebulizer Market accounted for US$ 1.2 billion in 2020 and is estimated to be US$ 2.29 billion by 2030 and is anticipated to register a CAGR of 6.8%.

Region Analysis:

In the nebulizers market, North America accounted largest revenue share of the market due to increasing respiratory disorders and efforts by the government such as favorable reimbursement scenario, well-established healthcare infrastructure, and growth in customer awareness. Additionally, favorable reimbursement scenario and introduction of technologically advanced devices in this region are anticipated to propel the market growth in this region.

Key Development:

  • In July 2020, Omron Healthcare the leading Japanese player in the home healthcare monitoring segment had announced addition of a new entrant to their compressor nebulizer portfolio-OMRON NE C106.
  • In June 2020, Respira technologies launched pharmaceutical-focused commercial development program for its RespiRx drug-delivery device platform. RespiRx is a portable, handheld vibrating mesh nebulizer designed for local and systemic treatment and can operate in any position held by the patient.


Nebulizer market accounted for US$ 1.2 billion in 2020 and is estimated to be US$ 2.29 billion by 2030 and is anticipated to register a CAGR of 6.8%. The global nebulizer market is segmented based on type, portability, sales, and region.

  • Based on the type, the target market is segmented into the pneumatic nebulizer, ultrasonic nebulizer, and mesh nebulizer.
  • Based on portability, the global market is classified into tabletop nebulizer and the portable nebulizer.
  • Based on sales, the target market is bifurcated direct purchase and online purchase.
  • On region the Nebulizer market is segmented into North America, Europe, Asia Pacific, Latin America, and Middle East & Africa.

Competitive Analysis:                                                                                                 

The key players operating in the global nebulizer market includes Agilent Technologies, Becton, Dickinson and Company, Briggs Healthcare, Drive DeVilbiss Healthcare, GF Health Products, Inc., Invacare Corporation, Koninklijke Philips N.V., Medline Industries, Inc., Omron Corporation, and PARI Pharma.

To know more

Contact Us:


Prophecy Market Insights

U.S: 1 860 531 2574

RoW: 91 7775049802




Buy Now
Need a Custom Report?

We can customize every report - free of charge - including purchasing stand-alone sections or country-level reports

Custmoized Your Report
Want to Buy a Report but have a Limited Budget?

We help clients to procure the report or sections of the report at their budgeted price. Kindly click on the below to avail

Request for Discount
Reliability and Reputation
Trusted By

Created billion dollars of revenue impact with more than 200+ clients

View All Our Clients